Vytorin Falls Short of New Indication for CKD Patients Family Practice News Digital Network This was despite the unanimous recommendation of the FDA's Endocrinologic and Metabolic Drugs Advisory Committee in November to approve Vytorin for reducing major cardiovascular events in patients with CKD who are not on dialysis. FDA Rejects Proposed Chronic Kidney Disease Indication for Vytorin Forbes all 4 news articles »

...